Bicocca Open Archive

Logo unimib boa
LOCATELLI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.276
EU - Europa 4.246
AS - Asia 1.595
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 9
OC - Oceania 9
Totale 16.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.094
IT - Italia 901
DE - Germania 696
CN - Cina 628
SG - Singapore 519
IE - Irlanda 514
SE - Svezia 514
UA - Ucraina 463
RU - Federazione Russa 382
GB - Regno Unito 273
CA - Canada 181
HK - Hong Kong 173
FI - Finlandia 134
AT - Austria 98
ID - Indonesia 67
IN - India 65
FR - Francia 60
DK - Danimarca 54
TR - Turchia 49
BE - Belgio 41
VN - Vietnam 41
NL - Olanda 39
BG - Bulgaria 20
JP - Giappone 16
PL - Polonia 16
CH - Svizzera 11
EU - Europa 11
KR - Corea 11
BR - Brasile 10
IR - Iran 9
CZ - Repubblica Ceca 8
AU - Australia 6
EE - Estonia 5
RO - Romania 5
TW - Taiwan 5
EG - Egitto 4
ES - Italia 4
SC - Seychelles 4
NZ - Nuova Zelanda 3
PT - Portogallo 3
CL - Cile 2
HU - Ungheria 2
IL - Israele 2
MY - Malesia 2
PK - Pakistan 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
SI - Slovenia 1
TJ - Tagikistan 1
Totale 16.160
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Woodbridge 1.090
Fairfield 979
Houston 784
Chandler 735
Wilmington 716
Ashburn 527
Frankfurt am Main 525
Jacksonville 504
Dublin 493
Seattle 441
Singapore 441
Dearborn 323
Cambridge 310
Milan 238
New York 215
Princeton 211
Hong Kong 172
Santa Clara 172
Nanjing 135
Vienna 97
Lawrence 87
Altamura 86
Lachine 82
Shanghai 77
Beijing 69
Jakarta 67
Boardman 57
Helsinki 48
Detroit 44
Nanchang 41
Brussels 40
Falls Church 40
San Diego 40
London 39
Rome 37
Guangzhou 34
Hebei 32
Andover 28
Mountain View 26
Shenyang 26
Huizen 24
Changsha 23
Elora 23
Toronto 23
Fremont 22
Grafing 20
Jiaxing 20
Tianjin 20
Chicago 18
Ottawa 18
Philadelphia 18
Renton 18
Hangzhou 17
Kunming 17
Pune 17
Plovdiv 16
Jinan 14
Norwalk 13
Monza 12
Ningbo 12
Romola 12
Munich 11
Auburn Hills 10
Bologna 10
Dong Ket 10
Sacramento 10
Turin 10
Carate Brianza 9
Lissone 9
Los Angeles 9
Edmonton 8
Pavia 8
Russi 8
Taizhou 8
Thunder Bay 8
Tokyo 8
University Park 8
Bari 7
Dallas 7
Kiev 7
Kocaeli 7
Zhengzhou 7
Chiavari 6
Leawood 6
Modena 6
Pisa 6
Rho 6
San Mateo 6
Southend 6
Tappahannock 6
Virginia Beach 6
Arcore 5
Bergamo 5
Bonndorf 5
Bresso 5
Padova 5
Paris 5
Tallinn 5
Washington 5
Totale 12.363
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 348
Growth hormone secretagogues and the regulation of calcium signaling in muscle 321
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 272
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 268
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 254
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 232
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 232
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 219
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 210
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 209
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 207
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 206
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 206
Neurotrophic and neuroregenerative effects of GH/IGF1 200
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 197
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 194
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 190
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 189
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 188
Feeding behavior during long-term hexarelin administration in young and old rats 186
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 186
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 185
Ghrelin in gastroenteric pathophysiology 181
Somatotropic dysregulation in old mammals 181
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 177
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 175
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 174
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 172
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 170
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 168
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 166
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 166
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 165
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 165
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 164
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 164
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 164
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 164
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 162
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 162
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 158
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 158
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 157
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 156
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 156
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 155
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 152
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 151
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 151
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 151
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 149
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 149
Growth hormone-inhibiting activity of cortistatin in the rat 148
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 148
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 147
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 147
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 146
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 145
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 144
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 143
Growth hormone-independent cardioprotective effects of hexarelin in the rat 142
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 141
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 141
Pyruvate and satiety: can we fool the brain? 139
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 138
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 137
La valutazione delle attività di tirocinio pratico da parte dei tutori 136
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 135
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 135
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 135
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 134
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 134
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 133
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 132
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 132
Low dose of insulin for assessment of growth hormone and cortisol release in short children 131
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 130
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 130
Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes 129
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 129
Testosterone a key factor in gender related metabolic syndrome 129
La somatopausa: nuove prospettive terapeutiche 126
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 122
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 121
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 116
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 115
L’accesso a Medicina. Best evidence-based practice, requisito indispensabile per una ipotesi di “Processo di Selezione” centrato sulla realtà formativa italiana e di caratura internazionale 114
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 114
Ghrelin expression in gut endocrine growths 112
New active series of growth hormone secretagogues 110
EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man 107
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action 107
Ghrelin anticonvulsive properties: is it a matter of desacylation? 103
Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat 102
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 100
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 99
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 98
Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment 97
Studio osservazionale comparativo su un campione di studenti del Nord, del Centro e del Sud con valutazione della Maturità, del Test di accesso e delle scelte di sede effettuate al concorso con graduatoria nazionale 2013-2014. Osservazioni preliminari. 92
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 92
Totale 15.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.650
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.347 0 0 0 0 0 0 409 232 300 147 198 61
2020/20211.872 122 112 197 228 149 160 173 150 153 214 83 131
2021/20221.199 63 109 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20251.550 215 352 234 239 349 161 0 0 0 0 0 0
Totale 16.589